Cleared Traditional

K931715 - PURECARE AT-903 T.E.N.S.

K931715 is an FDA 510(k) clearance for PURECARE AT-903 T.E.N.S., manufactured by Fuching Enterprise Co., Ltd.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 296-day FDA review.

K931715 · Fuching Enterprise Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1994
Decision
296d
Days
Class 2
Risk

K931715 is an FDA 510(k) clearance for the PURECARE AT-903 T.E.N.S.. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Fuching Enterprise Co., Ltd. (Great Neck, US). The FDA issued a Cleared decision on January 27, 1994 after a review of 296 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fuching Enterprise Co., Ltd. devices

FDA 510(k) Submission Details - K931715

510(k) Number K931715 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 1993
Decision Date January 27, 1994
Days to Decision 296 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
148d slower than avg
Panel avg: 148d · This submission: 296d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 288
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K931715.
THERAPEUTIC ULTRASOUND AND STIMULATOR
K935324 · Chattanooga Group, Inc. · May 1994
HOME MICROCURRENT HMC
K935132 · Medical Devices, Inc. · Mar 1994
FLEXMATE
K934619 · Medical Devices, Inc. · Feb 1994
K-STIM CLEAR
K922202 · Katecho, Inc. · May 1993
THERA PULSE A ELECTRO NERVE STIMULATOR
K925686 · Biomedical Life Systems, Inc. · Mar 1993
SD-602 SD MODE 11, SD-603 SD MOD 111
K925729 · Skylark Device Co., Ltd. · Jan 1993